Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis von Ungar, B., Mazor, Y., Weisshof, R., Yanai, H., Ron, Y., Goren, I., Waizbard, A., Yavzori, M., Fudim, E., Picard, O., Loebstein, R., Kopylov, U., Dotan, I., Chowers, Y., Eliakim, R., Ben‐Horin, S.

Volltext

PP272-MON: Outstanding abstract : Iron, B12, and Folic Acid. have we Forgotten ABC? von Weisshof, R, Mashiach, T, Chermesh, I

Volltext

PP126-MON: Hypophosphatemia in IBD Patients von Weisshof, R, Mashiach, T, Chermesh, I

Volltext

P285 A retrospective observational study on the effectiveness and safety of vedolizumab with or without budesonide induction therapy among patients with moderate-to-severe Crohn’s... von Weisshof, R, Vavricka, S, Pouillon, L, Braegger, F, Roset, M, Bent-Ennakhil, N, Ferrante, M

Volltext

P586 Tofacitinib for the induction and maintenance of medically resistant ulcerative colitis von Weisshof, R, Aharoni Golan, M, Rubin, D T

Volltext

P619 Tofacitinib for the treatment of resistant ulcerative colitis: the University of Chicago experience von Weisshof, R., Aharoni Golan, M., Masching, A., Rubin, D.T.

Volltext

DOP79 Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series von Albshesh, A, Eder, P, Ribaldone, D G, Oldenburg, B, De Boer, N K, Mantzaris, G J, Savarino, E V, Dragoni, G, Weisshof, R, Truyens, M, Festa, S, Maillard, M H, Capirchio, L, Filip, R, Kopylov, U

Volltext

P522 Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis von Avni Biron, I, Bar-Gil Shitrit, A, Koslowsky, B, Kopylov, U, Levartovsky, A, Weisshof, R, Aviv-Cohen, N, Maharshak, N, Hovel, D, Naftali, T, Goren, I, Snir, I, Ollech, J, Banai, H, Lena, B, Dotan, I, Yanai, H

Volltext

P529 Longer duration of vancomycin prevents recurrence of C. difficile in patients with inflammatory bowel disease von Lei, D, Andersen, M J, Weisshof, R, Meter, N, Rubin, D T

Volltext

P358 Ustekinumab is effective for the treatment of chronic antibiotic-refractory pouchitis von Ollech, J E, Glick, L, Weisshof, R, Israel, A, El Jurdi, K, Krugliak Cleveland, N, Cohen, R D, Dalal, S R, Rubin, D T

Volltext

P344 Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study von Ungaro, R, Fenster, M, Dimopoulos, C, Patel, A, Deepak, P, Syal, G, Yarur, A, Hirten, R, Christophi, G, Khatiwada, A, Lin, B, Colombel, J-F, Ha, C, Weisshof, R, Beniwal-Patel, P, Cohen, B, Pekow, J

Volltext

P407 Real-world safety of tofacitinib in inflammatory bowel diseases: a multi-centre study von Yarur, A, Bixuan, L, Deepak, P, Khatiwada, A, Christophi, G, Ciorba, M, Ungaro, R, Fenster, M, Dimopoulos, C, Syal, G, Hirten, R, Colombel, J-F, Ha, C, Weisshof, R, Pekow, J, Patel, A, Beniwal-Patel, P, Cohen, B

Volltext

P082 A cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of IBD patients von Gaujoux, R, Starosvetsky, E, Maimon, N, Vallania, F, Bar-Yoseph, H, Pressman, S, Weisshof, R, Goren, I, Waterman, M, Yanai, H, Dotan, I, Sabo, E, Chowers, Y, Khatri, P, Shen-Orr, S S

Volltext

Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational... von Weisshof, Roni, Vavricka, Stephan R, Pouillon, Lieven, Braegger, Fiona, Roset, Montserrat, Bent-Ennakhil, Nawal, Ferrante, Marc

Volltext

Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational... von Weisshof, Roni, Vavricka, Stephan R, Pouillon, Lieven, Braegger, Fiona, Roset, Montserrat, Bent-Ennakhil, Nawal, Ferrante, Marc

Volltext

Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational... von Weisshof, Roni, Vavricka, Stephan R, Pouillon, Lieven, Braegger, Fiona, Roset, Montserrat, Bent-Ennakhil, Nawal, Ferrante, Marc

Volltext

Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease von Ollech, Jacob E., Aharoni-Golan, Maya, Weisshof, Roni, Normatov, Inessa, Sapp, Abby R., Kalakonda, Aditya, Israel, Amanda, Glick, Laura R., Karrison, Theodore, Dalal, Sushila R., Sakuraba, Atsushi, Cohen, Russell D., Rubin, David T., Pekow, Joel

Volltext

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis von Ollech, Jacob E., Rubin, David T., Glick, Laura, Weisshof, Roni, El Jurdi, Katia, Israel, Amanda, Krugliak Cleveland, Noa, Hyman, Neil, Sakuraba, Atsushi, Pekow, Joel, Cohen, Russell D., Dalal, Sushila R.

Volltext

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study von Allegretti, Jessica R., Rubin, David T., Germinaro, Matthew, Huang, Kuan-Hsiang (Gary), Shipitofsky, Nicole, Wilson, Rebbecca, Han, Chenglong, Feagan, Brian G., Sandborn, William J., Panés, Julian, Hisamatsu, Tadakazu, Lichtenstein, Gary R., Dignass, Axel, Afanasieva, Halyna, Aitova, Lilia, Altintas, Engin, Altwegg, Romain, Andreev, Pavel, Aomatsu, Kazuki, Balestrieri, Paola, Brunatto, Luciana, Bulgheroni, Diego, Cabello, Mercedes, Cao, Qian, Caprioli, Flavio, Cerqueira, Rute, Chiu, Cheng-Tang, Choi, Chang Hwan, Dewint, Pieter, Dutré, Joris, Duvall, George, Fernandez, Juan, Filip, Rafal, Fogel, Ronald, Fowler, Sharyle, Fujii, Toshimitsu, Fukata, Masayuki, Furumoto, Yohei, Gasbarrini, Antonio, Gionchetti, Paolo, Goldin, Eran, Gonciarz, Maciej, Gonen, Can, Gyokeres, Tibor, Hébuterne, Xavier, Hellström, Per, Horný, Ivo, Hoshi, Namiko, Hrdlicka, Ludek, Ishihara, Shunji, Jang, Byung Ik, Kagaya, Takashi, Kanmura, Shuji, Katsuhiko, Nakai, Kiss, Gyula G., Klaus, Jochen, Kleczkowski, Dariusz, Klopocka, Maria, Kopon, Adam, Kravchenko, Tetiana, Kwon, Kwang An, Lago, Paula, Leszczyszyn, Jaroslaw, Marusawa, Hiroyuki, Miyabayashi, Hideharu, Mohl, Wolfgang, Motoya, Satoshi, Murali, Narayanachar, Nakajima, Koichi, Nakamoto, Yasunari, Nancey, Stéphane, Neto, Joaquim, Onizawa, Michio, Ono, Yohei, Osipenko, Marina, Patel, Bhaktasharan, Petrova, Elina, Poroshina, Elena, Prystupa, Lyudmyla, Roblin, Xavier, Romatowski, Jacek, Sakuraba, Hirotake, Schulze, Joerg, Shin, Sung Jae, Stanislavchuk, Mykola, Stokesberry, David, Suzuki, Takayoshi, Taguchi, Hiroki, Thin, Lena, Torrealba, Leyanira, Tsarynna, Nataliia, Tulassay, Zsolt, Ueo, Tetsuya, Valuyskikh, Ekaterina, Wei, Shu-Chen, Weisshof, Roni, Wojcik, Katarzyna, Yoshida, Kosuke, Zaha, Osamu, Zhan, Qiang

Volltext

797 – Real-World Safety of Tofacitinib in Inflammatory Bowel Diseases: A Multi-Center Study von Deepak, Parakkal, Khatiwada, Aava, Christophi, George P., Yarur, Andres J., Lin, Bixuan, Ciorba, Matthew A., Ungaro, Ryan C., Fenster, Marc, Dimopoulos, Christina, Patel, Anish, Bader, Geoffrey, Syal, Gaurav, Hirten, Robert, Colombel, Jean Frederic, Ha, Christina, Weisshof, Roni, Pekow, Joel R., Cohen, Benjamin L., Beniwal-Patel, Poonam M.

Volltext